Medicine pack check sheet

Source-linked reading points

• Check REGLAN, metoclopramide, oral-tablet form, the stated 5 or 10 mg per tablet, NDC, actual pack and target market together. Mg is the labelled amount in an exact tablet, not a web rule for how many tablets an individual should use, and it cannot self-convert an injection, oral solution, orally disintegrating tablet, another-market product or another medicine.
• The label's boxed warning concerns tardive dyskinesia and states that risk relates to treatment duration and total cumulative exposure. This warning is a cue to check the exact leaflet and complete medicine list; a webpage must not turn it into an individual start, reduction, stopping, continuation or switching instruction. New involuntary movements or an acute serious concern involving consciousness or breathing require local urgent-care channels first.
• The label identifies interaction cues involving antipsychotics, central-nervous-system depressants, strong CYP2D6 inhibitors and MAO inhibitors, and flags Parkinson's disease, epilepsy, prior movement disorders, liver/kidney context, age and multiple medicines for professional review. Have a pharmacist or prescribing team check every prescription, OTC product, herb and supplement together with the actual packs; do not self-combine or substitute simply because names look similar or both are described as gastrointestinal medicines.
• This page corresponds to a 2026 U.S. prescription-tablet label and cannot replace the current leaflet supplied with the product in hand. For a missed use, swallowing difficulty, pack mismatch, contemplated splitting/crushing or any treatment change, first have a pharmacist or care team familiar with the actual product and target-market label review it.